Michelle Cowan1, W James Chon, Amishi Desai, Sarah Andrews, Yaohui Bai, Vic Veguilla, Jacqueline M Katz, Michelle A Josephson, Patrick C Wilson, Roger Sciammas, Anita S Chong. 1. 1 Department of Surgery, The University of Chicago, Chicago, IL. 2 Department of Medicine, The University of Chicago, Chicago, IL. 3 Department of Pathology, The University of Chicago, Chicago, IL. 4 Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA. 5 Atlanta Research and Education Foundation, Atlanta, GA. 6 Address correspondence to: Anita S. Chong, Ph.D., The University of Chicago, 5841 S. Maryland Ave, Chicago, IL 60637.
Abstract
BACKGROUND: The recommendation by the American Society of Transplantation for annual trivalent inactivated influenza vaccination greater than 3 to 6 months post-kidney transplantation provides a unique opportunity to test the in vivo impact of immunosuppression on recall T- and B-cell responses to influenza vaccination. METHODS: This study took advantage of recent breakthroughs in the single-cell quantification of human peripheral blood B-cell responses to prospectively evaluate both B- and T-cell responses to the seasonal (2010 and 2011) influenza vaccine in 23 stable renal transplant recipients and 22 healthy controls. RESULTS AND CONCLUSION: The results demonstrate that the early B-cell response to influenza vaccination, quantified by the frequency of influenza-specific antibody-secreting cells (ASC) in peripheral blood, was significantly reduced in stable transplant recipients compared to healthy controls. The magnitude of the seroresponse and the rate of seroconversion were also blunted. The influenza-specific interferon-gamma (IFNγ) T-cell response was significantly reduced in transplant recipients; however, there was no correlation between the magnitude of the influenza-specific IgG ASC and IFNγ responses. The induction of memory T- and B-cell responses to influenza vaccination supports the recommendation to vaccinate while the blunted responses demonstrate the efficacy of immunosuppression in controlling memory responses individual transplant recipients.
BACKGROUND: The recommendation by the American Society of Transplantation for annual trivalent inactivated influenza vaccination greater than 3 to 6 months post-kidney transplantation provides a unique opportunity to test the in vivo impact of immunosuppression on recall T- and B-cell responses to influenza vaccination. METHODS: This study took advantage of recent breakthroughs in the single-cell quantification of human peripheral blood B-cell responses to prospectively evaluate both B- and T-cell responses to the seasonal (2010 and 2011) influenza vaccine in 23 stable renal transplant recipients and 22 healthy controls. RESULTS AND CONCLUSION: The results demonstrate that the early B-cell response to influenza vaccination, quantified by the frequency of influenza-specific antibody-secreting cells (ASC) in peripheral blood, was significantly reduced in stable transplant recipients compared to healthy controls. The magnitude of the seroresponse and the rate of seroconversion were also blunted. The influenza-specific interferon-gamma (IFNγ) T-cell response was significantly reduced in transplant recipients; however, there was no correlation between the magnitude of the influenza-specific IgG ASC and IFNγ responses. The induction of memory T- and B-cell responses to influenza vaccination supports the recommendation to vaccinate while the blunted responses demonstrate the efficacy of immunosuppression in controlling memory responses individual transplant recipients.
Authors: D Kumar; E A Blumberg; L Danziger-Isakov; C N Kotton; N B Halasa; M G Ison; R K Avery; M Green; U D Allen; K M Edwards; G Miller; M G Michaels Journal: Am J Transplant Date: 2011-10 Impact factor: 8.086
Authors: Gui-Mei Li; Christopher Chiu; Jens Wrammert; Megan McCausland; Sarah F Andrews; Nai-Ying Zheng; Jane-Hwei Lee; Min Huang; Xinyan Qu; Srilatha Edupuganti; Mark Mulligan; Suman R Das; Jonathan W Yewdell; Aneesh K Mehta; Patrick C Wilson; Rafi Ahmed Journal: Proc Natl Acad Sci U S A Date: 2012-05-21 Impact factor: 11.205
Authors: Lara Danziger-Isakov; Leonid Cherkassky; Hanni Siegel; Mary McManamon; Kristen Kramer; Marie Budev; Deirdre Sawinski; Joshua J Augustine; Donald E Hricik; Robert Fairchild; Peter S Heeger; Emilio D Poggio Journal: Transplantation Date: 2010-04-15 Impact factor: 4.939
Authors: Undine Ott; Andreas Sauerbrei; Jeannette Lange; Anna Schäfler; Mario Walther; Gunter Wolf; Peter Wutzler; Roland Zell; Andi Krumbholz Journal: Med Microbiol Immunol Date: 2012-02-17 Impact factor: 3.402
Authors: Adeyemi Lawal; Chris Basler; Andrea Branch; Julio Gutierrez; Myron Schwartz; Thomas D Schiano Journal: Am J Transplant Date: 2004-11 Impact factor: 8.086
Authors: Shivaprakash Gangappa; Jens Wrammert; David Wang; Zhu-Nan Li; Justine S Liepkalns; Weiping Cao; Jufu Chen; Min Z Levine; James Stevens; Suryaprakash Sambhara; Beth Begley; Aneesh Mehta; Thomas C Pearson; Rafi Ahmed; Christian P Larsen Journal: Transpl Immunol Date: 2019-01-18 Impact factor: 1.708
Authors: Katlyn Lederer; Emily Bettini; Kalpana Parvathaneni; Mark M Painter; Divyansh Agarwal; Kendall A Lundgreen; Madison Weirick; Kavitha Muralidharan; Diana Castaño; Rishi R Goel; Xiaoming Xu; Elizabeth M Drapeau; Sigrid Gouma; Jordan T Ort; Moses Awofolaju; Allison R Greenplate; Carole Le Coz; Neil Romberg; Jennifer Trofe-Clark; Gregory Malat; Lisa Jones; Mark Rosen; Daniela Weiskopf; Alessandro Sette; Behdad Besharatian; Mary Kaminiski; Scott E Hensley; Paul Bates; E John Wherry; Ali Naji; Vijay Bhoj; Michela Locci Journal: Cell Date: 2022-02-02 Impact factor: 66.850
Authors: Victor H Ferreira; Javier T Solera; Queenie Hu; Victoria G Hall; Berta G Arbol; W Rod Hardy; Reuben Samson; Tina Marinelli; Matthew Ierullo; Avneet Kaur Virk; Alexandra Kurtesi; Faranak Mavandadnejad; Beata Majchrzak-Kita; Vathany Kulasingam; Anne-Claude Gingras; Deepali Kumar; Atul Humar Journal: Nat Commun Date: 2022-08-04 Impact factor: 17.694